Guoqing Li, 41Lowell, MA

2021033, Oct 28, 2021

Aug 16, 2019

17/268995

- Rahway NJ, US
Xavier Fradera - Brookline MA, US
Liangqin Guo - Monroe NJ, US
Yongxin Han - Needham MA, US
Shuwen He - Fanwood NJ, US
Xianhai Huang - Warren NJ, US
Joseph Kozlowski - Princeton NJ, US
Guoqing Li - Belle Mead NJ, US
Jongwon Lim - Lexington MA, US
Theodore A. Martinot - Southborough MA, US
Alexander Pasternak - Jamaica Plain MA, US
Nunzio Sciammetta - Sudbury MA, US
Andreas Verras - New York NY, US
Li Xiao - Cranbury NJ, US
Wensheng Yu - Edison NJ, US
Rui Zhang - Plainsboro NJ, US

Merck Sharp & Dohme Corp. - Rahway NJ

A61K 31/5377
A61K 45/06
C07D 401/14
C07D 401/06
C07D 413/14
C07D 451/06
A61K 31/4545
A61K 31/496
A61K 31/454
A61K 31/46

Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

2020023, Jul 23, 2020

Aug 24, 2017

16/326408

- RAHWAY NJ, US
Abdelghani Achab - Melrose MA, US
Purakkattle Biju - Westwood MA, US
Timothy A. Cernak - Boston MA, US
Yongqi Deng - Newton MA, US
Xavier Fradera - Needham MA, US
Liangqin Guo - Monroe NJ, US
Yongxin Han - Needham MA, US
Shuwen He - Fanwood NJ, US
Joseph Kozlowski - Princeton NJ, US
Derun Li - West Roxbury MA, US
Guoqing Li - Belle Mead NJ, US
Qinglin Pu - Needham MA, US
Zhi-Cai Shi - Monmouth Junction NJ, US
Wensheng Yu - Edison NJ, US
Hongjun Zhang - Boston MA, US

Merck Sharp & Dohme Corp. - Rahway NJ

C07F 5/02
C07D 271/08
C07D 413/12

Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I). Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

2020010, Apr 2, 2020

Mar 23, 2018

16/495883

- Rahway NJ, US
Yongxin Han - Needham MA, US
Kun Liu - Needham MA, US
Shuwen He - Fanwood NJ, US
Joseph Kozlowski - Princeton NJ, US
Ravi Nargund - East Brunswick NJ, US
Wensheng Yu - Edison NJ, US
Hongjun Zhang - Boston MA, US
Qinglin Pu - Needham MA, US
Derun Li - Brighton MA, US
Abdelghani Achab - Melrose MA, US
Guoqing Li - Belle Mead NJ, US

Merck Sharp & Dohme Corp. - Rahway NJ

C07D 271/08
C07D 413/12

Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof. Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.